BAP1 and Hyperglycemia: Hyperglycemia also resulted in a minor decrease in nuclear BAP1 immunoreactivity in the 92.1 and OMM2.5 cells under interphase, with an average reduction by 16% to 18% in the integrated density and mean intensity, respectively, of both cell lines, which failed to reach significance (Supplementary Fig. S2).